Ufp Technologies (UFPT) Income from Non-Controlling Interests (2010 - 2011)
Ufp Technologies posted quarterly Income from Non-Controlling Interests of $4601.0 for Q4 2011, down 96.14% year-on-year from $119079.0 in Q4 2010, and up 4.21% on a QoQ basis from $4415.0 in Q3 2011.
Ufp Technologies (UFPT) has 2 years of Income from Non-Controlling Interests data on file, last reported at $4601.0 in Q4 2011.
- For the quarter ending Q4 2011, Income from Non-Controlling Interests fell 96.14% year-over-year to $4601.0; the trailing twelve-month figure through Dec 2011 stood at $438000.0 (changed N/A YoY), and the FY2011 full-year result was $438000.0, up 173.02% from the prior year.
- Income from Non-Controlling Interests for Q4 2011 stood at $4601.0, up from $4415.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $428285.0 in Q1 2011 and bottomed at $699.0 in Q2 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 4,601.00 |
| Sep 30, 2011 | 4,415.00 |
| Jun 30, 2011 | 699.00 |
| Mar 31, 2011 | 428,285.00 |
| Dec 31, 2010 | 119,079.00 |
| Sep 30, 2010 | 14,554.00 |
| Jun 30, 2010 | 15,729.00 |